Stock EXDW EXCEED WORLD, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Exceed World, Inc.

Equities

EXDW

US30067B1026

Drug Retailers

Market Closed - OTC Markets
Other stock markets
 12:41:32 2024-05-14 EDT 		5-day change 1st Jan Change
0.55 USD +7.84% Intraday chart for Exceed World, Inc. +7.84% +7.84%
02-16 Exceed World, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
01-05 Exceed World, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023 CI

Valuation

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Capitalization 1 11.9 19.62 16.35 63.76 26.81 22.89
Enterprise Value (EV) 1 -11.13 -1.607 -3.207 41.12 3.455 5.361
P/E ratio 10.4 x -149 x -16.7 x 21.7 x 6.48 x -35 x
Yield - - - - - -
Capitalization / Revenue 0.34 x 0.69 x 0.78 x 2.24 x 0.77 x 0.88 x
EV / Revenue -0.32 x -0.06 x -0.15 x 1.45 x 0.1 x 0.21 x
EV / EBITDA -4.42 x 4.54 x 4.4 x 9.3 x 0.53 x -20.5 x
EV / FCF -1.26 x 0.51 x 92.1 x 8.89 x 0.68 x -1.04 x
FCF Yield -79.6% 198% 1.09% 11.2% 147% -95.8%
Price to Book 1.24 x 1.1 x 0.95 x 3.36 x 1.51 x 1.38 x
Nbr of stocks (in thousands) 20,000 32,700 32,700 32,700 32,700 32,700
Reference price 2 0.5950 0.6000 0.5000 1.950 0.8200 0.7000
Announcement Date 1/14/19 3/20/20 1/13/21 1/13/22 1/9/23 1/5/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Net sales 1 34.88 28.39 21.02 28.43 34.69 25.92
EBITDA 1 2.516 -0.3542 -0.7296 4.424 6.505 -0.262
EBIT 1 1.396 -0.4743 -0.8681 4.304 6.408 -0.3855
Operating Margin 4% -1.67% -4.13% 15.14% 18.47% -1.49%
Earnings before Tax (EBT) 1 1.069 0.3142 -0.9538 3.966 6.662 -0.2656
Net income 1 1.159 -0.132 -0.9623 3.075 4.138 -0.5517
Net margin 3.32% -0.46% -4.58% 10.81% 11.93% -2.13%
EPS 2 0.0574 -0.004037 -0.0300 0.0900 0.1266 -0.0200
Free Cash Flow 1 8.863 -3.179 -0.0348 4.624 5.071 -5.136
FCF margin 25.41% -11.2% -0.17% 16.26% 14.62% -19.81%
FCF Conversion (EBITDA) 352.23% - - 104.53% 77.95% -
FCF Conversion (Net income) 764.98% - - 150.41% 122.53% -
Dividend per Share - - - - - -
Announcement Date 1/14/19 3/20/20 1/13/21 1/13/22 1/9/23 1/5/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 23 21.2 19.6 22.6 23.4 17.5
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 8.86 -3.18 -0.03 4.62 5.07 -5.14
ROE (net income / shareholders' equity) 7.64% -0.76% -5.51% 17% 22.5% -3.21%
ROA (Net income/ Total Assets) 3.47% -1.07% -2.1% 9.95% 14.2% -0.94%
Assets 1 33.42 12.29 45.75 30.91 29.23 58.85
Book Value Per Share 2 0.4800 0.5400 0.5200 0.5800 0.5400 0.5100
Cash Flow per Share 2 0.7000 0.6200 0.5900 0.7100 0.7300 0.5600
Capex - 0.22 0.03 0.01 0.11 0.09
Capex / Sales - 0.79% 0.14% 0.04% 0.3% 0.35%
Announcement Date 1/14/19 3/20/20 1/13/21 1/13/22 1/9/23 1/5/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Drug Retailers

1st Jan change Capi.
EXCEED WORLD, INC. Stock Exceed World, Inc.
+7.84% 17.98M
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-29.72% 15.83B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-22.89% 12.31B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-24.53% 6.59B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+15.23% 6.45B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-12.43% 5.94B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-1.90% 4.66B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+62.00% 4.59B
CLICKS GROUP LIMITED Stock Clicks Group Limited
-5.94% 3.96B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-9.36% 3.55B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. EXDW Stock
  4. Financials Exceed World, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW